SPY310.52+2.16 0.70%
DIA257.31-0.56 -0.22%
IXIC10,154.63+95.86 0.95%

Zogenix shares are trading higher after the company announced the FDA has approved Zogenix's new therapy for Dravet syndrome.

Benzinga · -